LIFE-U:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund (USD)

ETF | Others |

Last Closing

CAD 21.07

Change

0.00 (0.00)%

Market Cap

N/A

Volume

800.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.37 (+1.34%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.17 (-0.34%)

CAD 4.88B
PHYS-U:CA Sprott Physical Gold Trust

-0.04 (-0.22%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.21 (-0.32%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.27 (-1.19%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.16 (+0.53%)

CAD 3.67B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.15 (+0.69%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.05 (+0.24%)

CAD 2.52B

ETFs Containing LIFE-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.53% 35% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.53% 34% F 32% F
Trailing 12 Months  
Capital Gain -1.08% 13% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.08% 12% F 22% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.65% 20% F 25% F
Dividend Return -2.64% 20% F 18% F
Total Return 0.02% 16% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 5.66% 66% D+ 84% B
Risk Adjusted Return -46.63% 19% F 12% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.